Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?

Ahsan Ali Khan; Professor Gregory Lip

doi:10.1093/eurheartj/ehz005

Back

Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?

Article 2019 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2016

Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life

Michela Giustozzi, Maria Cristina Vedovati, Paolo Verdecchia, Lucia Pierpaoli, Melina Verso, Serenella Conti, F Cianella, Emanuela Marchesini, Esmeralda Filippucci, Giancarlo Agnelli, Cecilia Becattini

Book2015

Non-Vitamin K Antagonist Oral Anticoagulants

Eduard Shantsila, Professor Gregory Lip

Article2017

Postapproval Observational Studies of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation

Tatjana Potpara, Professor Gregory Lip

Article2021

Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding

Soonil Kwon, So-Ryoung Lee, Eue-Keun Choi, Euijae Lee, Jin‐Hyung Jung, Kyungdo Han, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip

Article2019

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease

Inki Moon, So-Ryoung Lee, Eue-Keun Choi, Euijae Lee, Jin‐Hyung Jung, Kyungdo Han, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip